A central tenet in the use of local therapy for breast cancer is patient choice. Survival and rates of local recurrence do not differ significantly among patients undergoing breast-conserving therapy (BCT) or mastectomy,1 and the widespread use of adjuvant systemic therapy has led to substantial decreases in the risk of local recurrence and contralateral breast cancer,2 making BCT a more attractive choice for patients. Paradoxically, increasing numbers of women with unilateral cancer choose to undergo bilateral mastectomy, and this trend is most pronounced among young women.3 This occurrence presents a challenge for breast surgeons who seek to respect patient autonomy.
Identify all potential conflicts of interest that might be relevant to your comment.
Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.
Err on the side of full disclosure.
If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.
Not all submitted comments are published. Please see our commenting policy for details.
Morrow M. Quality of Life and Breast Cancer Surgery. JAMA Surg. Published online September 01, 2021. doi:10.1001/jamasurg.2021.3759
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: